| New interleukins in psoriasis and psoriatic arthritis patients: the possible roles of interleukin-33 to interleukin-38 in disease activities and bone erosions J Li, L Liu, W Rui, X Li, D Xuan, S Zheng, Y Yu, J Zhang, N Kong, X Zhu, ... Dermatology 233 (1), 37-46, 2017 | 88 | 2017 |
| Sirt1 ameliorates monosodium urate crystal–induced inflammation by altering macrophage polarization via the PI3K/Akt/STAT6 pathway L Liu, X Zhu, T Zhao, Y Yu, Y Xue, H Zou Rheumatology 58 (9), 1674-1683, 2019 | 65 | 2019 |
| Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout L Liu, Y Xue, Y Zhu, D Xuan, X Yang, M Liang, J Wang, X Zhu, J Zhang, ... Arthritis research & therapy 18, 1-14, 2016 | 65 | 2016 |
| SIRT1 prevents hyperuricemia via the PGC-1α/PPARγ-ABCG2 pathway J Wang, XX Zhu, L Liu, Y Xue, X Yang, HJ Zou Endocrine 53, 443-452, 2016 | 43 | 2016 |
| Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathway X Zhu, H Chu, S Jiang, Q Liu, L Liu, Y Xue, S Zheng, W Wan, J Qiu, ... Journal of Dermatological Science 87 (2), 149-158, 2017 | 41 | 2017 |
| Kimura’s disease or IgG4-related disease? A case-based review L Liu, Y Chen, Z Fang, J Kong, X Wu, Z Zhang Clinical rheumatology 34, 385-389, 2015 | 40 | 2015 |
| Characteristics of patients with primary Sjögren’s syndrome associated interstitial lung disease and relevant features of disease progression T Zhang, F Yuan, L Xu, W Sun, L Liu, J Xue Clinical rheumatology 39, 1561-1568, 2020 | 36 | 2020 |
| Distinct macrophage polarization in acute and chronic gout L Zhao, W Ye, Y Zhu, F Chen, Q Wang, X Lv, Y Hua, Z Du, X Zhu, Y Yu, ... Laboratory Investigation 102 (10), 1054-1063, 2022 | 24 | 2022 |
| Leptin promotes IL‑18 secretion by activating the NLRP3 inflammasome in RAW 264.7 cells S Fu, L Liu, L Han, Y Yu Molecular medicine reports 16 (6), 9770-9776, 2017 | 22 | 2017 |
| Recent insights into the role of macrophages in acute gout L Liu, L Zhu, M Liu, L Zhao, Y Yu, Y Xue, L Shan Frontiers in immunology 13, 955806, 2022 | 21 | 2022 |
| Estradiol regulates intestinal ABCG2 to promote urate excretion via the PI3K/Akt pathway L Liu, T Zhao, L Shan, L Cao, X Zhu, Y Xue Nutrition & Metabolism 18 (1), 63, 2021 | 20 | 2021 |
| Clinical association of chemokine (CXC motif) ligand 1 (CXCL1) with interstitial pneumonia with autoimmune features (IPAF) M Liang, Z Jiang, Q Huang, L Liu, Y Xue, X Zhu, Y Yu, W Wan, H Yang, ... Scientific Reports 6 (1), 38949, 2016 | 18 | 2016 |
| Differential long non-coding RNA expression profile and function analysis in primary Sjogren’s syndrome X Chen, Q Cheng, Y Du, L Liu, H Wu BMC immunology 22, 1-13, 2021 | 17 | 2021 |
| Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody T Yan, X Zhang, H Yang, W Sun, L Liu, Y Du, J Xue Clinical Rheumatology 40, 3695-3702, 2021 | 15 | 2021 |
| Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis L Xu, L Jiang, L Nie, S Zhang, L Liu, Y Du, J Xue BMC immunology 22, 1-10, 2021 | 13 | 2021 |
| Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody H Wang, X Chen, Y Du, L Wang, Q Wang, H Wu, L Liu, J Xue Arthritis Research & Therapy 25 (1), 127, 2023 | 11 | 2023 |
| Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China L Wen, X Chen, Q Cheng, L Nie, J Xu, T Yan, X Zhang, H Yang, W Sun, ... Clinical rheumatology 41 (11), 3419-3427, 2022 | 10 | 2022 |
| Vasoactive intestinal peptide‐induced tolerogenic dendritic cells attenuated arthritis in experimental collagen‐induced arthritic mice H Wu, J Shen, L Liu, X Lu, J Xue International journal of rheumatic diseases 22 (7), 1255-1262, 2019 | 10 | 2019 |
| 2015 年美国风湿病学会/欧洲抗风湿病联盟痛风分类标准评述 杨雪， 刘磊， 朱小霞， 邹和建 中华风湿病学杂志 20 (2), 141-143, 2016 | 10 | 2016 |
| NXP2‐positive dermatomyositis complicated with refractory skin edema: Successful treatment with tocilizumab. Z Lu, Y Chen, J Xue, L Liu Dermatologic Therapy 34 (1), 2021 | 7 | 2021 |
